Resources for people who are living with lupus nephritis
When you're fighting a serious disease every day, finding the time to understand and manage your treatment can feel overwhelming and lonely. Aurinia Alliance® is here to help every step of the way, so you can focus on what's more important—you.
When you enroll, you'll receive:
- A Dedicated Nurse Case Manager
- Lupus Nephritis and LUPKYNIS® Educational Materials
- Financial Assistance
- A Welcome Kit
Emili Z., RNC-MNN
Nurse Case Manager
See what's inside the LUPKYNIS® Welcome Kit
Your dedicated Nurse Case Manager will send you a Welcome Kit to help you get started on your treatment journey. Inside you'll find:
A Welcome Brochure
With helpful information about taking LUPKYNIS and how to get support from Aurinia Alliance.
An Instructional Card
To help you open your LUPKYNIS blister packs.
A LUPKYNIS Medication Carrier
Designed by someone living with lupus nephritis, so you can stylishly store and carry your medication. It's water resistant and has a pocket to store important information.
An Aurinia Alliance Magnet and Dry Erase Marker
Where you can track your daily doses and jot down appointments and reminders.
Get personalized support with a Nurse Case Manager
If you're taking LUPKYNIS, when you enroll in Aurinia Alliance you'll be connected with a Nurse Case Manager. They'll be your dedicated contact throughout your Aurinia treatment journey.
Your Nurse Case Manager will provide resources, including
Lupus nephritis educational materials
Lupus nephritis is a serious and complex disease—and learning about it can quickly become overwhelming. Wherever you are in your journey, your Nurse Case Manager can provide you with helpful information that is tailored to your specific needs. Here are some materials to get started:
Getting Started with LUPKYNIS Brochure (English)Getting Started with LUPKYNIS Brochure (Español)Doctor Discussion GuideFind more information about lupus nephritis
Financial assistance
Navigating a treatment plan for a serious condition like lupus nephritis can come with concerns about how to afford treatment. Because every situation is unique, your Nurse Case Manager is available to help you understand your insurance benefits not only when you begin treatment, but also if your insurance plan changes. They can also answer your questions about financial assistance for which you may be eligible.
97% of the time*, patients paid less than $10 for their LUPKYNIS prescription.
*97% of the shipments of LUPKYNIS delivered cost the patient $10 or less. These are patients on commercial insurance, Medicaid or Medicare from January 2023 to December 2023.
Already enrolled?
Get in touch with your Nurse Case Manager to access
your exclusive resources at 1-833-AURINIA (1-833-287-4642)
"Aurinia has provided a great deal of support. Just having a source that allowed me to talk freely about what I was experiencing helped me feel validated, and to know I was not alone."
– Tiffany, started treatment 2021
"Sometimes knowing that you are not alone helps you cope with what you're going through."
– Nancy, started treatment in 2021, pictured with her care partner Jose
Frequently asked questions
Will I be able to afford treatment with LUPKYNIS?
Everyone's situation is different, but when you enroll with Aurinia Alliance, your Nurse Case Manager will partner with you and walk through all the options available to you based on your individual coverage.
Aurinia also offers a copay program for eligible commercial patients. $0 copay for eligible commercial patients.
97% of the time*, patients paid less than $10 for their LUPKYNIS prescription.
Who do I talk to if I have questions about my treatment?
If you have questions specifically about LUPKYNIS or any other aspects of your lupus nephritis treatment, you should always talk to your doctor. When you enroll in Aurinia Alliance, you'll be connected with a dedicated Nurse Case Manager who will provide the consistency and expertise needed to help you navigate your LUPKYNIS treatment journey. Sign up here to get started. You can also enroll by calling 1-833-AURINIA (1-833-287-4642).
IMPORTANT SAFETY INFORMATION
BOXED WARNING: MALIGNANCIES AND SERIOUS INFECTIONS
LUPKYNIS increases the risk of serious infections and malignancies that may result in hospitalization or death. See full Prescribing Information for complete BOXED WARNING.
IMPORTANT SAFETY INFORMATION
BOXED WARNING: MALIGNANCIES AND SERIOUS INFECTIONS
LUPKYNIS increases the risk of serious infections and malignancies that may result in hospitalization or death. See full Prescribing Information for complete BOXED WARNING.
CONTRAINDICATIONS
- DO NOT use with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin).
- DO NOT use LUPKYNIS if a patient has a history of serious hypersensitivity reactions, including anaphylaxis, to LUPKYNIS or any of its components.
WARNINGS AND PRECAUTIONS
- Nephrotoxicity may occur. Monitor eGFR and adjust dose as needed.
- Hypertension is common. Monitor blood pressure. May require antihypertensive therapy; watch for possibility of drug interactions with some antihypertensives.
- Neurotoxicity: Monitor for neurologic symptoms including risk of posterior reversible encephalopathy syndrome (PRES).
- Hyperkalemia: Monitor potassium, especially with concomitant agents associated with hyperkalemia.
- QT Prolongation: Monitor ECG and electrolytes in high-risk patients.
- Hypersensitivity Reactions (Including Anaphylaxis and Angioedema): Monitor and discontinue if reaction occurs.
- Pure Red Cell Aplasia: Monitor and consider discontinuation if diagnosed.
- Immunizations: Avoid live vaccines.
- Lymphomas and Other Cancers: Immunosuppressants increase the risk of lymphomas and other cancers, especially of the skin. Monitor for skin changes and advise sun protection and avoidance of artificial UV light.
ADVERSE REACTIONS
The most common adverse reactions (≥3% and ≥2% against placebo) include decreased GFR, hypertension, diarrhea, headache, anemia, cough, urinary tract infection, abdominal pain upper, dyspepsia, alopecia, renal impairment, abdominal pain, mouth ulceration, fatigue, tremor, acute kidney injury, and decreased appetite. Nausea and vomiting have been reported during post-approval use.
SPECIFIC POPULATIONS
Pregnancy: Inform female patients of the potential risk to a fetus and to avoid use of LUPKYNIS during pregnancy.
These are not all the possible side effects of LUPKYNIS. For more information, ask your healthcare provider. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to www.fda.gov/medwatch.
WHAT IS LUPKYNIS?
LUPKYNIS is a prescription medicine used with other medicines to treat adults with active lupus nephritis. LUPKYNIS should not be taken with a medicine called cyclophosphamide. Talk with your healthcare provider if you are not sure if you take this medicine.
Please see full Prescribing Information, including BOXED WARNING, and Medication Guide for additional Important Safety Information about LUPKYNIS.